Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (371-380 of 531) with videos related to

Pageof 54
Sort By:
Antibiotics (Basel, Switzerland)|October 17, 2020
Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic ModelJacinda C Abdul-Mutakabbir, Razieh Kebriaei, Kyle C Stamper, et al.
Infectious Diseases and Therapy|September 24, 2018
Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare SettingKimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
Journal of Applied Microbiology|June 2, 2022
Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testingDana J Holger, Katherine L Lev, Razieh Kebriaei, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2015
Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditisAnthony M Casapao, Thomas P Lodise, Susan L Davis, et al.
Diagnostic Microbiology and Infectious Disease|July 19, 2017
Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factorsTrang D Trinh, Evan J Zasowski, Kimberly C Claeys, et al.
Pharmacotherapy|March 1, 1997
A pharmacist-initiated program of intravenous to oral antibiotic conversionK G Przybylski, M J Rybak, P R Martin, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2016
Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumanniiGeorge Sakoulas, Warren Rose, Andrew Berti, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infectionsEarl R Kern, Caroll B Hartline, Rachel J Rybak, et al.
Journal of Clinical Microbiology|April 19, 2013
Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methodsMichael J Rybak, Celine Vidaillac, Helio S Sader, et al.
Infectious Diseases and Therapy|December 19, 2018
Risk Factors for Bloodstream Infections Among an Urban Population with Skin and Soft Tissue Infections: A Retrospective Unmatched Case-Control StudyMichael J Rybak, Evan J Zasowski, Sarah C J Jorgensen, et al.
Pageof 54

Showing results (371-380 of 531) with videos related to

Sort By:
Pageof 54
Antibiotics (Basel, Switzerland)|October 17, 2020
Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic ModelJacinda C Abdul-Mutakabbir, Razieh Kebriaei, Kyle C Stamper, et al.
Infectious Diseases and Therapy|September 24, 2018
Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare SettingKimberly C Claeys, Evan J Zasowski, Abdalhamid M Lagnf, et al.
Journal of Applied Microbiology|June 2, 2022
Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testingDana J Holger, Katherine L Lev, Razieh Kebriaei, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2015
Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditisAnthony M Casapao, Thomas P Lodise, Susan L Davis, et al.
Diagnostic Microbiology and Infectious Disease|July 19, 2017
Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factorsTrang D Trinh, Evan J Zasowski, Kimberly C Claeys, et al.
Pharmacotherapy|March 1, 1997
A pharmacist-initiated program of intravenous to oral antibiotic conversionK G Przybylski, M J Rybak, P R Martin, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2016
Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumanniiGeorge Sakoulas, Warren Rose, Andrew Berti, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infectionsEarl R Kern, Caroll B Hartline, Rachel J Rybak, et al.
Journal of Clinical Microbiology|April 19, 2013
Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methodsMichael J Rybak, Celine Vidaillac, Helio S Sader, et al.
Infectious Diseases and Therapy|December 19, 2018
Risk Factors for Bloodstream Infections Among an Urban Population with Skin and Soft Tissue Infections: A Retrospective Unmatched Case-Control StudyMichael J Rybak, Evan J Zasowski, Sarah C J Jorgensen, et al.
Pageof 54